Home Newsletters Pulmonary Cell News Serum IL-35 Levels Is a New Candidate Biomarker of Cancer-Related Cachexia in...

Serum IL-35 Levels Is a New Candidate Biomarker of Cancer-Related Cachexia in Stage IV Non-small Cell Lung Cancer

0
Investigators revealed that high serum IL-35 expression was associated with NSCLC cachexia and skeletal muscle atrophy.
[Thoracic Cancer]
7992332 {7992332:AAAAAAAA} apa 50 1 171686 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
Full Article
Exit mobile version